Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00596726 · ClinicalTrials.gov registry record · Phase 2

RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study

A Phase 2 study of Cardiac Surgery, sponsored by Abiomed.

Completed
Registry status
Phase 2
Development phase
17
Enrollment target
7
Study locations

NCT00596726: Completed Phase 2 study of Cardiac Surgery, sponsored by Abiomed.

NCT00596726 is a Phase 2 study of Cardiac Surgery that has completed, run by Abiomed. The registered enrollment target is 17 participants, below the 745-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (98% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00596726, a Phase 2 study of Cardiac Surgery, has completed, sponsored by Abiomed.

COMPLETED
Registry status
Phase 2
Development phase
17 participants
Enrollment target
7
Study locations

Study Summary

To demonstrate that that the device is safe and potentially efficacious for use as a left ventricular cardiac assist device for postcardiotomy patients who require hemodynamic support post weaning from cardiopulmonary bypass.

Conditions Studied

Interventions

  • DEVICE IMPELLA LP/LD 5.0

Study Locations (7)

Massachusetts

  • Massach General Hospital - Boston
  • Brigham & Womens - Boston

Maryland

  • University of Maryland - Baltimore

New Jersey

  • Robert Wood Johnson - New Brunswick

New York

  • Columbia Presbyterian Hospital - New York

Pennsylvania

  • Hershey Medical Center - Hershey

Texas

  • Texas Heart - Houston

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2006-08
Est. Completion 2010-05
Phase Phase 2
Abiomed

20 total trials

What the finished NCT00596726 record still lists

NCT00596726 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 745-participant average among 19 other Cardiac Surgery trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cardiac Surgery appearing as the primary indexed condition, and to 1 intervention - of which IMPELLA LP/LD 5.0 is the first listed.

NCT00596726 lists 7 locations in 6 states (Massachusetts, Maryland, New Jersey).

Frequently Asked Questions

What is clinical trial NCT00596726 about?

NCT00596726 is a clinical study titled "RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study". To demonstrate that that the device is safe and potentially efficacious for use as a left ventricular cardiac assist device for postcardiotomy patients who require hemodynamic support post weaning from cardiopulmonary bypass.

What is the current status of trial NCT00596726?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2006-08. Estimated completion is 2010-05.

What conditions does trial NCT00596726 study?

This clinical trial studies the following conditions: Cardiac Surgery.

What interventions are being tested in trial NCT00596726?

The interventions under investigation include: IMPELLA LP/LD 5.0 (DEVICE).

Who is sponsoring clinical trial NCT00596726?

This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00596726 being conducted?

This trial has 7 study locations across Maryland, Massachusetts, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00596726's enrollment target sits among peer trials

17 20th of 19 the lowest of 19 other Cardiac Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiac Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00596726, the US trial registry maintained by the National Library of Medicine. NCT00596726 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.